Editorial: Mechanistic insight and therapeutic potential for the management of non-alcoholic steatohepatitis (NASH)
2024

Insights on Non-Alcoholic Steatohepatitis Management

Editorial

Author Information

Author(s): Navik Umashanker, Khurana Amit, Singh Bhatti Jasvinder

Primary Institution: Central University of Punjab, Bathinda, India

Conclusion

The studies highlight the importance of gender-specific treatments and novel predictive tools for early detection of non-alcoholic steatohepatitis (NASH).

Supporting Evidence

  • Genistein has been shown to reduce obesity and insulin resistance in female mice.
  • HIF-2α exacerbates fibrosis in NAFLD through chronic hypoxia.
  • ALT is an effective marker for screening NAFLD, especially in males.
  • Higher glucose-to-albumin ratio is positively correlated with increased NAFLD risk.

Takeaway

This article talks about how different treatments for liver disease can work better for men and women, and how new tests can help find liver problems early.

Limitations

Further studies are required to validate new predictive tools and consider gender-specific approaches in screening.

Participant Demographics

The studies involve gonadectomized mice as a model for hormonal changes related to metabolic dysfunction, and human populations exposed to chronic hypoxia.

Digital Object Identifier (DOI)

10.3389/fendo.2024.1503460

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication